Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children
2008

Study of a Malaria Vaccine in Children

Sample size: 36 publication 10 minutes Evidence: moderate

Author Information

Author(s): Dicko Alassane, Sagara Issaka, Ellis Ruth D., Miura Kazutoyo, Guindo Ousmane, Kamate Beh, Sogoba Moussa, Niambelé Mohamed Balla, Sissoko Mady, Baby Mounirou, Dolo Amagana, Mullen Gregory E. D., Fay Michael P., Pierce Mark, Diallo Dapa A., Saul Allan, Miller Louis H., Doumbo Ogobara K.

Primary Institution: Malaria Research and Training Center, University of Bamako, Mali

Hypothesis

The study aims to assess the safety and immunogenicity of the AMA1-C1 malaria vaccine in young children in a malaria endemic area.

Conclusion

The AMA-C1 vaccine is well tolerated and immunogenic in children in this endemic area, although the antibody response was short-lived.

Supporting Evidence

  • The vaccine was well tolerated with no severe adverse events.
  • Antibody responses were significantly higher in children receiving the vaccine compared to the control.
  • Responses peaked at Day 42 but decreased by Day 154.

Takeaway

This study tested a malaria vaccine in young children and found it to be safe and effective at making their bodies produce antibodies, but those antibodies didn't last long.

Methodology

This was a Phase 1 dose escalating study in 36 healthy children aged 2–3 years, randomized to receive either the AMA1-C1 vaccine or a control vaccine.

Potential Biases

Potential bias due to the double-blind design, but the study was well-monitored for compliance.

Limitations

The study was limited to a small sample size and only assessed short-term antibody responses.

Participant Demographics

36 healthy children aged 2-3 years, with 19 males and 17 females.

Statistical Information

P-Value

0.0003

Confidence Interval

95% CI (12–68.3) for 20 µg group, 95% CI (17.5–42.0) for 80 µg group

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001563

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication